Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2006-4-28
pubmed:abstractText
A whole-cell-based assay using Saccharomyces cerevisiae strains that overexpress Candida albicans CDR1 and MDR1 efflux pumps has been employed to screen natural product extracts for reversal of fluconazole resistance. The tropical green alga Penicillus capitatus was selected for bioassay-guided isolation, leading to the identification of capisterones A and B (1 and 2), which were recently isolated from this alga and shown to possess antifungal activity against the marine pathogen Lindra thallasiae. Current work has assigned their absolute configurations using electronic circular dichroism and determined their preferred conformations in solution based on detailed NOE analysis. Compounds 1 and 2 significantly enhanced fluconazole activity in S. cerevisiae, but did not show inherent antifungal activity when tested against several opportunistic pathogens or cytotoxicity to several human cancer and noncancerous cell lines (up to 35 microM). These compounds may have a potential for combination therapy of fungal infections caused by clinically relevant azole-resistant strains.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16643022-10348760, http://linkedlifedata.com/resource/pubmed/commentcorrection/16643022-10691711, http://linkedlifedata.com/resource/pubmed/commentcorrection/16643022-10944295, http://linkedlifedata.com/resource/pubmed/commentcorrection/16643022-11000025, http://linkedlifedata.com/resource/pubmed/commentcorrection/16643022-11494597, http://linkedlifedata.com/resource/pubmed/commentcorrection/16643022-12019079, http://linkedlifedata.com/resource/pubmed/commentcorrection/16643022-12088430, http://linkedlifedata.com/resource/pubmed/commentcorrection/16643022-12580616, http://linkedlifedata.com/resource/pubmed/commentcorrection/16643022-12608862, http://linkedlifedata.com/resource/pubmed/commentcorrection/16643022-12662099, http://linkedlifedata.com/resource/pubmed/commentcorrection/16643022-12880315, http://linkedlifedata.com/resource/pubmed/commentcorrection/16643022-12932143, http://linkedlifedata.com/resource/pubmed/commentcorrection/16643022-14620391, http://linkedlifedata.com/resource/pubmed/commentcorrection/16643022-14695809, http://linkedlifedata.com/resource/pubmed/commentcorrection/16643022-15058939, http://linkedlifedata.com/resource/pubmed/commentcorrection/16643022-15174849, http://linkedlifedata.com/resource/pubmed/commentcorrection/16643022-15281819, http://linkedlifedata.com/resource/pubmed/commentcorrection/16643022-8158167, http://linkedlifedata.com/resource/pubmed/commentcorrection/16643022-9564569
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0163-3864
pubmed:author
pubmed:issnType
Print
pubmed:volume
69
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
542-6
pubmed:dateRevised
2011-5-4
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Capisterones A and B, which enhance fluconazole activity in Saccharomyces cerevisiae, from the marine green alga Penicillus capitatus.
pubmed:affiliation
National Center for Natural Products Research and Department of Pharmacognosy, Research Institute of Pharmaceutical Sciences, School of Pharmacy, The University of Mississippi, University, MS 38677, USA. xcli@olemiss.edu
pubmed:publicationType
Journal Article